R&D & Funding
If the UK leaves the EU under the terms of the new Withdrawal Agreement on the 31 January 2020, there will be no change to the current arrangements for EU-related R&D and funding during the Transition Period until 31 December 2020.
At the end of the Transition Period, depending on the terms of any future relationship agreed with the EU, there are likely to be changes that could affect to business’ R&D activities and funding.
The following is the official guidance previously provided by the Government relating to the life sciences industry, focusing on how to prepare for a no-deal outcome.
Please see the Regulation & IP page
UK regulations on access to genetic resources and the fair and equitable sharing of benefits arising from their utilisation (the Nagoya Protocol) that will continue to be operable after the UK leaves the EU